Xolair 300 MG/2 ML autoinject 2ML

Ended Awarded Last action

Contract number
SPE2DR26FHLC0
Awardee
Awarding agency
Obligated
$19,222

Award facts

Contract value 100% obligated
$19,221.84 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $19,221.84 delivery order to DMS Pharmaceutical Group Inc. on April 1, 2026, for XOLAIR 300 MG/2 ML AUTOINJECT 2ML pharmaceutical supplies, with an ultimate completion date of April 22, 2026.

This order was issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a firm fixed-price indefinite delivery contract. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. Place of performance is Park Ridge, IL. The order carries no set-aside designation.

Quick answers

Who was awarded contract SPE2DR26FHLC0?

SPE2DR26FHLC0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 1, 2026.

How much is contract SPE2DR26FHLC0 worth?

The government has obligated $19,222 on SPE2DR26FHLC0.

Is contract SPE2DR26FHLC0 an order under another contract?

Yes. SPE2DR26FHLC0 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.

Was contract SPE2DR26FHLC0 competed?

The extent of competition for SPE2DR26FHLC0 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award